MENU
+Compare
ACB
Stock ticker: NASDAQ
AS OF
Aug 15, 12:33 PM (EDT)
Price
$5.23
Change
-$0.16 (-2.97%)
Capitalization
303.5M

ACB Aurora Cannabis Forecast, Technical & Fundamental Analysis

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard... Show more

ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACB with price predictions
Aug 14, 2025

ACB's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ACB turned positive on August 11, 2025. Looking at past instances where ACB's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 11, 2025. You may want to consider a long position or call options on ACB as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ACB moved above its 50-day moving average on August 11, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACB advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 90 cases where ACB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ACB moved out of overbought territory on August 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACB broke above its upper Bollinger Band on August 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.757) is normal, around the industry mean (19.695). P/E Ratio (19.440) is within average values for comparable stocks, (72.379). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.837). ACB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (1.161) is also within normal values, averaging (40.299).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACB is expected to report earnings to rise 15.15% to 6 cents per share on November 06

Aurora Cannabis ACB Stock Earnings Reports
Q3'25
Est.
$0.07
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.39
Q3'24
Missed
by $0.08
The last earnings report on August 06 showed earnings per share of 5 cents, missing the estimate of 9 cents. With 338.35K shares outstanding, the current market capitalization sits at 303.50M.
A.I. Advisor
published General Information

General Information

a licensed producer of medical marijuana in Canada

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3498 63 Avenue
Phone
+1 855 279-4652
Employees
1130
Web
https://www.auroramj.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRNWF0.06N/A
+3.61%
Greenlane Renewables Inc.
NGGTF14.770.11
+0.75%
National Grid PLC
CHBAF8.01N/A
N/A
Chiba Bank, Ltd. (The)
NZEOF0.20N/A
N/A
ECHELON RES LTD.
FRBP10.25N/A
N/A
FRANKLIN BSP CAPITAL CORP

ACB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with SNDL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-2.53%
SNDL - ACB
65%
Loosely correlated
-1.40%
CGC - ACB
64%
Loosely correlated
-9.15%
OGI - ACB
59%
Loosely correlated
-2.50%
CRON - ACB
56%
Loosely correlated
-3.82%
TLRY - ACB
54%
Loosely correlated
-5.60%
More

Groups containing ACB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-2.53%
ACB
(2 stocks)
96%
Closely correlated
-4.34%
Pharmaceuticals: Generic
(227 stocks)
15%
Poorly correlated
-0.57%